Survival from cancer varies with many factors, including: demographic characteristics, tumour type, stage of the cancer at diagnosis, co-morbidities, other prognostic indicators
Survival from cancer can be influenced by various factors including demographic characteristics, tumour type, stage of the cancer at diagnosis, other prognostic indicators and a
In 2010, it was estimated that alcohol-attributable cancer was responsible for about 4.2% of all global cancer deaths, and 4.6% of all potential Years-of-Life-Lost as a result o
In 2010, it was estimated that alcohol-attributable cancer was responsible for about 4.2% of all global cancer deaths, and 4.6% of all potential Years-of-Life-Lost as a result o
In 2010, it was estimated that alcohol-attributable cancer was responsible for about 4.2% of all global cancer deaths, and 4.6% of all potential Years-of-Life-Lost.7
In 2010, it was estimated that alcohol-attributable cancer was responsible for about 4.2 percent of all global cancer deaths, and 4.6 percent of all potential ‘Years-of-Life-Los
The MIR provides a crude measure of the fatality of a selected cancer type relative to other cancers (higher MIR values indicate poorer survival).1,2 The MIR can hel
Overweight and obesity is calculated using the Body Mass Index (BMI), a scale based on height and weight commonly used to define if a person is underweight, normal weight, overw
The measure ‘proportion of people aged 18 years and over who participated in less than 150 minutes or less than five sessions of physical activity, including walking for fitness
The measure "Radiotherapy treatment activity" presents data for radiotherapy services delivered in Australia between 2013 and 2015, as indicated by reimbursement claims under th
Relative survival by stage at diagnosis (female breast cancer)
5306
2700
4
This measure presents national survival by stage at diagnosis data for female breast cancer in Australia using data sources that are routinely accessible to all cancer registrie
This measure shows the number of people receiving at least one of the cancer-related systemic therapies and a small number of supportive treatments in Australia in any one year
